Angela R. Omilian, Ph.D. - Publications

Affiliations: 
Indiana University, Bloomington, Bloomington, IN, United States 
Area:
Evolution

40/72 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Abdou Y, Attwood K, Cheng TD, Yao S, Bandera EV, Zirpoli GR, Ondracek RP, Stein L, Bshara W, Khoury T, Ambrosone CB, Omilian AR. Racial differences in CD8 T cell infiltration in breast tumors from Black and White women. Breast Cancer Research : Bcr. 22: 62. PMID 32517730 DOI: 10.1186/S13058-020-01297-4  0.371
2020 Omilian AR, Wei L, Hong CC, Bandera EV, Liu S, Khoury T, Ambrosone CB, Yao S. Somatic mutations of triple-negative breast cancer: a comparison between Black and White women. Breast Cancer Research and Treatment. PMID 32441016 DOI: 10.1007/S10549-020-05693-4  0.38
2020 Llanos AAM, Lin Y, Chen W, Yao S, Norin J, Chekmareva MA, Omene C, Cong L, Omilian AR, Khoury T, Hong CC, Ganesan S, Foran DJ, Higgins M, Ambrosone CB, et al. Immunohistochemical analysis of adipokine and adipokine receptor expression in the breast tumor microenvironment: associations of lower leptin receptor expression with estrogen receptor-negative status and triple-negative subtype. Breast Cancer Research : Bcr. 22: 18. PMID 32046756 DOI: 10.1186/S13058-020-1256-3  0.346
2020 Bandera EV, Demissie K, Qin B, Llanos AAM, Lin Y, Xu B, Pawlish K, Plascak JJ, Tsui J, Omilian AR, McCann W, Yao S, Ambrosone CB, Hong CC. The Women's Circle of Health Follow-Up Study: a population-based longitudinal study of Black breast cancer survivors in New Jersey. Journal of Cancer Survivorship : Research and Practice. PMID 31907766 DOI: 10.1007/S11764-019-00849-8  0.345
2020 Abdou Y, Attwood K, Yao S, Cheng TD, Bandera E, Zirpoli G, Ondracek RP, Stein L, Bshara W, Khoury T, Ambrosone CB, Omilian A. Role of CD8+ T-cell infiltration in breast tumors of Black women compared to White women. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E13608  0.38
2020 Yao S, Cheng T, Elkhanany A, Yan L, Omilian A, Abrams SI, Evans S, Hong C, Qi Q, Davis W, Liu S, Bandera EV, Odunsi K, Takabe K, Khoury T, et al. Abstract IA26: Breast tumor microenvironment in black women: A distinct signature of CD8+ T-cell exhaustion Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-Ia26  0.346
2020 Abdou Y, Yao S, Attwood K, Zirpoli G, Bshara W, Ambrosone C, Omilian A. Abstract P2-10-02: Racial differences in infiltration of CD8+ T-cells in breast tumors of Black and White women Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P2-10-02  0.416
2019 Cheng TD, Yao S, Omilian AR, Khoury T, Buas MF, Payne-Ondracek R, Sribenja S, Bshara W, Hong CC, Bandera EV, Davis W, Higgins MJ, Ambrosone CB. FOXA1 protein expression in ER+ and ER- breast cancer in relation to parity and breastfeeding in Black and White women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31871111 DOI: 10.1158/1055-9965.Epi-19-0787  0.383
2019 Bunch B, Krishnan N, Greenspan RD, Ramakrishnan S, Attwood K, Yan L, Qi Q, Wang D, Morrison C, Omilian A, Bshara W, Pili R, Trump DL, Johnson C, Woloszynska A. TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC). Cell Cycle (Georgetown, Tex.). 1-12. PMID 31318640 DOI: 10.1080/15384101.2019.1638693  0.341
2019 Mukhopadhyay UK, Oturkar CC, Adams C, Wickramasekera N, Bansal S, Medisetty R, Miller A, Swetzig WM, Silwal-Pandit L, Borresen-Dale AL, Creighton CJ, Park JH, Konduri SD, Mukhopadhyay A, Caradori A, ... Omilian A, et al. TP53 Status as a Determinant of Pro- versus Anti-tumorigenic Effects of Estrogen Receptor-beta in Breast Cancer. Journal of the National Cancer Institute. PMID 30990221 DOI: 10.1093/Jnci/Djz051  0.329
2019 Elkhanany A, Takabe K, Khoury T, Omilian A, Cheng D, Katsuta E, Davis W, Yan L, Hong C, Bandera E, Ambrosone C, Yao S. Abstract P4-06-05: PanCancer profiling reveals population difference in breast cancer immune microenvironment Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-P4-06-05  0.352
2018 Purwaha P, Gu F, Piyarathna DWB, Rajendiran T, Ravindran A, Omilian AR, Jiralerspong S, Das G, Morrison C, Ambrosone C, Coarfa C, Putluri N, Sreekumar A. Unbiased Lipidomic Profiling of Triple-Negative Breast Cancer Tissues Reveals the Association of Sphingomyelin Levels with Patient Disease-Free Survival. Metabolites. 8. PMID 30011843 DOI: 10.3390/Metabo8030041  0.377
2018 Allott EH, Geradts J, Cohen SM, Khoury T, Zirpoli GR, Bshara W, Davis W, Omilian A, Nair P, Ondracek RP, Cheng TD, Miller CR, Hwang H, Thorne LB, O'Connor S, et al. Frequency of breast cancer subtypes among African American women in the AMBER consortium. Breast Cancer Research : Bcr. 20: 12. PMID 29409530 DOI: 10.1186/S13058-018-0939-5  0.361
2018 Yang Y, Attwood K, Versaggi C, Omilian A, Bshara W, Xu B, Kauffman E, Mohler J, Guru K, Li Q, George S, Basse P, Morrison C, Papanicolau-Sengos A, Kalinski P, et al. Association of high CD8+ tumor infiltrating lymphocytes at prostatectomy with improved survival of prostate cancer patients. Journal of Clinical Oncology. 36: 5068-5068. DOI: 10.1200/Jco.2018.36.15_Suppl.5068  0.331
2018 Anwer K, Matsuzaki J, Bshara W, Lugade A, Omilian A, Thaker PH, Bradley WH, Arend R, Gunderson C, Fewell J, Borys N, Musso L, Odunsi A. Abstract A76: Immunologic changes following intraperitoneal administration of a formulated IL-12 plasmid in combination with standard neoadjuvant chemo in newly diagnosed advanced stage ovarian cancer patients Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Ovca17-A76  0.337
2018 Pabla S, Conroy J, Nesline M, Glenn S, Burgher B, Qin M, Andreas J, Giamo V, Lenzo FL, Omilian A, Bshara W, Papanicolau-Sengos A, Wang Y, Ernstoff M, Gardner M, et al. Abstract 5070: Chemokine expression signatures in infiltrated vs non-infiltrated tumors Cancer Research. 78: 5070-5070. DOI: 10.1158/1538-7445.Am2018-5070  0.363
2018 Luo W, Ma Y, Cortes E, Omilian A, Bshara W, Azabdaftari G, Bunch B, Johnson C, Trump D. Abstract 4625: Tumor expression of PIM kinases in renal cell carcinoma and the association with disease progression Cancer Research. 78: 4625-4625. DOI: 10.1158/1538-7445.Am2018-4625  0.362
2018 Das GM, Mukhopadhyay UK, Adams C, Wickramasekera N, Medisetty R, Bansal S, Silwal-Pandit L, Borresen-Dale A, Miller A, Sweizig WM, Omilian A, Bshara W, Mukhopadhyay A. Abstract 3748: p53 status as a determinant of functional duality of estrogen receptor beta in breast cancer: Therapeutic implications Cancer Research. 78: 3748-3748. DOI: 10.1158/1538-7445.Am2018-3748  0.396
2018 Cheng TD, Ondracek RP, Yao S, Davis W, Omilian A, Opyrchal M, Bandera EV, Higgins MJ, Ambrosone CB, Khoury T. Abstract 3242: Differences in stromal tumor-infiltrating lymphocytes in breast cancer from women of African and European ancestry after accounting for tumor characteristics Epidemiology. 78: 3242-3242. DOI: 10.1158/1538-7445.Am2018-3242  0.412
2017 Conroy JM, Pabla S, Glenn ST, Burgher B, Nesline M, Papanicolau-Sengos A, Andreas J, Giamo V, Lenzo FL, Hyland FCL, Omilian A, Bshara W, Qin M, He J, Puzanov I, et al. Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid Tumors. The Journal of Molecular Diagnostics : Jmd. PMID 29061374 DOI: 10.1016/J.Jmoldx.2017.10.001  0.329
2017 Khoury T, Zirpoli G, Cohen SM, Geradts J, Omilian A, Davis W, Bshara W, Miller R, Mathews MM, Troester M, Palmer JR, Ambrosone CB. Ki-67 Expression in Breast Cancer Tissue Microarrays: Assessing Tumor Heterogeneity, Concordance With Full Section, and Scoring Methods. American Journal of Clinical Pathology. 148: 108-118. PMID 28898983 DOI: 10.1093/Ajcp/Aqx053  0.38
2017 Espinal AC, Buas MF, Wang D, Cheng DT, Sucheston-Campbell L, Hu Q, Yan L, Payne-Ondracek R, Cortes E, Tang L, Gong Z, Zirpoli G, Khoury T, Yao S, Omilian A, et al. FOXA1 hypermethylation: link between parity and ER-negative breast cancer in African American women? Breast Cancer Research and Treatment. PMID 28756535 DOI: 10.1007/S10549-017-4418-Y  0.359
2017 Attwood K, Fleyshman D, Prendergast L, Paszkiewicz G, Omilian AR, Bshara W, Gurova K. Prognostic value of histone chaperone FACT subunits expression in breast cancer. Breast Cancer (Dove Medical Press). 9: 301-311. PMID 28496363 DOI: 10.2147/BCTT.S126390  0.301
2017 Grabosch S, Tseng G, Edwards RP, Lankes HA, Moore K, Odunsi K, Vlad A, Ma T, Strange M, Brozick J, Lugade A, Omilian A, Bshara W, Stuckey AR, Walker JL, et al. Multiplex profiling identifies distinct local and systemic alterations during intraperitoneal chemotherapy for ovarian cancer: An NRG Oncology/Gynecologic Oncology Group Study. Gynecologic Oncology. PMID 28483269 DOI: 10.1016/J.Ygyno.2017.04.008  0.343
2017 Anwer K, Matsuzaki J, Bshara W, Lugade A, Omilian A, Thaker PH, Bradley WH, Leath CA, Gunderson CC, Fewell J, Borys N, Musso L, Odunsi K. Immunological changes following intraperitoneal administration of a formulated IL-12 plasmid in combination with standard neoadjuvant chemotherapy in patients with newly diagnosed advanced stage ovarian cancer. Journal of Clinical Oncology. 35: 156-156. DOI: 10.1200/Jco.2017.35.7_Suppl.156  0.33
2017 Davis L, Lenzo F, Ylagan L, Omilian A, Attwood K, Cance WG. FAK expression as a prognostic marker in colorectal cancer: A single institution study of 298 patients. Journal of Clinical Oncology. 35: 623-623. DOI: 10.1200/Jco.2017.35.4_Suppl.623  0.369
2016 Paluch BE, Glenn ST, Conroy JM, Papanicolau-Sengos A, Bshara W, Omilian AR, Brese E, Nesline M, Burgher B, Andreas J, Odunsi K, Eng K, He J, Qin M, Gardner M, et al. Robust detection of immune transcripts in FFPE samples using targeted RNA sequencing. Oncotarget. PMID 27911273 DOI: 10.18632/Oncotarget.13691  0.319
2016 Zhang W, Barger CJ, Eng KH, Klinkebiel D, Link PA, Omilian A, Bshara W, Odunsi K, Karpf AR. PRAME expression and promoter hypomethylation in epithelial ovarian cancer. Oncotarget. PMID 27322684 DOI: 10.18632/Oncotarget.9977  0.323
2016 Odunsi K, Tsuji T, Eng KH, Szender JB, Matsuzaki J, Miliotto A, Gnjatic S, Bshara W, Omilian A, Morrison CD, Lele SB, Emerson RO, Desmarais C, Wang J, Liu S, et al. Prognostic effects of peripheral and tumor-infiltrating T-cell repertoire diversity in ovarian cancer. Journal of Clinical Oncology. 34: 5546-5546. DOI: 10.1200/Jco.2016.34.15_Suppl.5546  0.357
2015 Greenspan RD, Krishnan N, Morrison C, Omilian A, Bshara W, Worral A, Attwood K, Trump DL, Woloszynska-Read A, Johnson CS. Abstract LB-158: P73, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle invasive bladder cancer (MIBC) Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-158  0.34
2014 Morrison CD, Liu P, Woloszynska-Read A, Zhang J, Luo W, Qin M, Bshara W, Conroy JM, Sabatini L, Vedell P, Xiong D, Liu S, Wang J, Shen H, Li Y, ... Omilian AR, et al. Whole-genome sequencing identifies genomic heterogeneity at a nucleotide and chromosomal level in bladder cancer. Proceedings of the National Academy of Sciences of the United States of America. 111: E672-81. PMID 24469795 DOI: 10.1073/Pnas.1313580111  0.384
2013 Wawrzyniak JA, Bianchi-Smiraglia A, Bshara W, Mannava S, Ackroyd J, Bagati A, Omilian AR, Im M, Fedtsova N, Miecznikowski JC, Moparthy KC, Zucker SN, Zhu Q, Kozlova NI, Berman AE, et al. A purine nucleotide biosynthesis enzyme guanosine monophosphate reductase is a suppressor of melanoma invasion. Cell Reports. 5: 493-507. PMID 24139804 DOI: 10.1016/J.Celrep.2013.09.015  0.325
2013 Garcia H, Miecznikowski JC, Safina A, Commane M, Ruusulehto A, Kilpinen S, Leach RW, Attwood K, Li Y, Degan S, Omilian AR, Guryanova O, Papantonopoulou O, Wang J, Buck M, et al. Facilitates chromatin transcription complex is an "accelerator" of tumor transformation and potential marker and target of aggressive cancers. Cell Reports. 4: 159-73. PMID 23831030 DOI: 10.1016/J.Celrep.2013.06.013  0.351
2013 Gurova KV, Garcia H, Miecznikowski J, Omilian AR, Morrison C. Level of SSRP1 in Cancer as a Prognostic Marker of Aggressive Disease American Journal of Clinical Pathology. 140: A152-A152. DOI: 10.1093/Ajcp/140.Suppl1.152  0.3
2012 Yang N, Morrison CD, Liu P, Miecznikowski J, Bshara W, Han S, Zhu Q, Omilian AR, Li X, Zhang J. TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin. Cell Cycle (Georgetown, Tex.). 11: 2922-30. PMID 22825057 DOI: 10.4161/Cc.21386  0.336
2011 Deeb KK, Luo W, Karpf AR, Omilian AR, Bshara W, Tian L, Tangrea MA, Morrison CD, Johnson CS, Trump DL. Differential vitamin D 24-hydroxylase/CYP24A1 gene promoter methylation in endothelium from benign and malignant human prostate. Epigenetics : Official Journal of the Dna Methylation Society. 6: 994-1000. PMID 21725204 DOI: 10.4161/Epi.6.8.16536  0.322
2009 Omilian AR, Lynch M. Patterns of intraspecific DNA variation in the Daphnia nuclear genome. Genetics. 182: 325-36. PMID 19304589 DOI: 10.1534/Genetics.108.099549  0.463
2008 Omilian AR, Scofield DG, Lynch M. Intron presence-absence polymorphisms in Daphnia. Molecular Biology and Evolution. 25: 2129-39. PMID 18667441 DOI: 10.1093/Molbev/Msn164  0.459
2007 Omilian AR, Cristescu MEA, Dudycha JL, Lynch M. Erratum: Ameiotic recombination in asexual lineages of Daphnia (Proceedings of the National Academy of Sciences of the United States of America (December 5, 2006) 103, 49 (18638-18643) DOI: 10.1073/pnas.0606435103) Proceedings of the National Academy of Sciences of the United States of America. 104. DOI: 10.1073/Pnas.0611148104  0.396
2006 Omilian AR, Cristescu ME, Dudycha JL, Lynch M. Ameiotic recombination in asexual lineages of Daphnia. Proceedings of the National Academy of Sciences of the United States of America. 103: 18638-43. PMID 17121990 DOI: 10.1073/Pnas.0606435103  0.449
Low-probability matches (unlikely to be authored by this person)
2012 Mannava S, Omilian AR, Wawrzyniak JA, Fink EE, Zhuang D, Miecznikowski JC, Marshall JR, Soengas MS, Sears RC, Morrison CD, Nikiforov MA. PP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cells. Oncogene. 31: 1484-92. PMID 21822300 DOI: 10.1038/Onc.2011.339  0.3
2019 Omilian AR, Zirpoli GR, Cheng TD, Yao S, Stein L, Davis W, Head KL, Nair P, Khoury T, Ambrosone CB, Bshara W. Storage Conditions and Immunoreactivity of Breast Cancer Subtyping Markers in Tissue Microarray Sections. Applied Immunohistochemistry & Molecular Morphology : Aimm. PMID 31205070 DOI: 10.1097/Pai.0000000000000756  0.292
2018 Cheng TD, Darke AK, Redman MW, Zirpoli GR, Davis W, Payne Ondracek R, Bshara W, Omilian AR, Kratzke R, Reid ME, Molina JR, Kolesar JM, Chen Y, MacRae RM, Moon J, et al. Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424). Journal of the National Cancer Institute. PMID 29346580 DOI: 10.1093/Jnci/Djx260  0.289
2012 Liu Y, Cheney RT, Omilian A, Morrison C, Xu B. Expression of PAX2 and Renal Cell Carcinoma Antigen in Mucoepidermoid Carcinoma North American Journal of Medicine & Science. 5: 203. DOI: 10.7156/Najms.2012.054203  0.286
2011 Xu S, Omilian AR, Cristescu ME. High rate of large-scale hemizygous deletions in asexually propagating Daphnia: implications for the evolution of sex. Molecular Biology and Evolution. 28: 335-42. PMID 20675410 DOI: 10.1093/Molbev/Msq199  0.283
2001 Omilian AR, Taylor DJ. Rate acceleration and long-branch attraction in a conserved gene of cryptic daphniid (Crustacea) species. Molecular Biology and Evolution. 18: 2201-12. PMID 11719570 DOI: 10.1093/Oxfordjournals.Molbev.A003767  0.28
2021 Omilian AR, Sheng H, Hong CC, Bandera EV, Khoury T, Ambrosone CB, Yao S. Multiplexed digital spatial profiling of invasive breast tumors from Black and White women. Molecular Oncology. PMID 34018684 DOI: 10.1002/1878-0261.13017  0.28
2016 Wei L, Papanicolau-Sengos A, Liu S, Wang J, Conroy JM, Glenn ST, Brese E, Hu Q, Miles KM, Burgher B, Qin M, Head K, Omilian AR, Bshara W, Krolewski J, et al. Pitfalls of improperly procured adjacent non-neoplastic tissue for somatic mutation analysis using next-generation sequencing. Bmc Medical Genomics. 9: 64. PMID 27756300 DOI: 10.1186/S12920-016-0226-1  0.278
2022 Khoury T, Aljabab S, Yao S, Ambrosone C, Omilian A, Attwood K, Ji W, Gandhi S. Tumor-associated mononuclear cells in the tumor bed of triple-negative breast cancer associate with clinical outcomes in the post-neoadjuvant chemotherapy setting. Breast Cancer Research and Treatment. PMID 35716216 DOI: 10.1007/s10549-022-06641-0  0.277
2012 Crease TJ, Omilian AR, Costanzo KS, Taylor DJ. Transcontinental phylogeography of the Daphnia pulex species complex. Plos One. 7: e46620. PMID 23056371 DOI: 10.1371/Journal.Pone.0046620  0.271
2018 Conroy J, Pabla S, Nesline M, Glenn S, Burgher B, Qin M, Andreas J, Giamo V, Lenzo FL, Omilian A, Bshara W, Papanicolau-Sengos A, Wang Y, Ernstoff M, Gardner M, et al. Abstract 4526: Predicting response: PD-L1 biomarker testing by IHC and RNA-seq Cancer Research. 78: 4526-4526. DOI: 10.1158/1538-7445.Am2018-4526  0.269
2020 Llanos AAM, Yao S, Singh A, Aremu JB, Khiabanian H, Lin Y, Omene C, Omilian AR, Khoury T, Hong CC, Ganesan S, Foran DJ, Higgins MJ, Ambrosone CB, Bandera EV, et al. Gene expression of adipokines and adipokine receptors in the tumor microenvironment: associations of lower expression with more aggressive breast tumor features. Breast Cancer Research and Treatment. PMID 33067778 DOI: 10.1007/s10549-020-05972-0  0.268
2022 Ilozumba MN, Yao S, Llanos AAM, Omilian AR, Zhang W, Datta S, Hong CC, Davis W, Khoury T, Bandera EV, Higgins M, Ambrosone CB, Cheng TD. mTOR pathway gene expression in association with race and clinicopathological characteristics in Black and White breast cancer patients. Discover. Oncology. 13: 34. PMID 35608730 DOI: 10.1007/s12672-022-00497-y  0.26
2020 Cheng TD, Omilian AR, Yao S, Sanchez PV, Polk LZ, Zhang W, Datta S, Bshara W, Ondracek RP, Davis W, Liu S, Hong CC, Bandera EV, Khoury T, Ambrosone CB. Body fatness and mTOR pathway activation of breast cancer in the Women's Circle of Health Study. Npj Breast Cancer. 6: 45. PMID 33024820 DOI: 10.1038/s41523-020-00187-4  0.258
2010 Rivera AS, Pankey MS, Plachetzki DC, Villacorta C, Syme AE, Serb JM, Omilian AR, Oakley TH. Gene duplication and the origins of morphological complexity in pancrustacean eyes, a genomic approach. Bmc Evolutionary Biology. 10: 123. PMID 20433736 DOI: 10.1186/1471-2148-10-123  0.255
2018 Albain K, Darke A, Mack P, Redman M, Cheng T, Moon J, Holland W, Borczuk A, Chay C, Morris P, Vallieres E, Kratzke R, Molina J, Kolesar J, Chen Y, ... ... Omilian A, et al. OA06.01 Case-Series Study in Ever- and Never-Smoking Females and Males with NSCLC: Exposures, Tumor Factors, Biology and Survival (SWOG S0424) Journal of Thoracic Oncology. 13: S333. DOI: 10.1016/J.Jtho.2018.08.263  0.254
2007 McTaggart SJ, Dudycha JL, Omilian A, Crease TJ. Rates of recombination in the ribosomal DNA of apomictically propagated Daphnia obtusa lines Genetics. 175: 311-320. PMID 17110499 DOI: 10.1534/Genetics.105.050229  0.254
2014 Byrd K, Maxwell G, Bshara W, Risinger J, Tian C, Omilian A, Odunsi K, Morrison C, Conrads T, Consortium W. Subcellular localization of AT-rich interactive domain1A protein expression is associated with survival in epithelial ovarian and peritoneal carcinoma Gynecologic Oncology. 133: 93-94. DOI: 10.1016/J.Ygyno.2014.03.249  0.252
2015 Wei L, Liu S, Conroy J, Wang J, Papanicolau-Sengos A, Glenn ST, Murakami M, Liu L, Hu Q, Conroy J, Miles KM, Nowak DE, Liu B, Qin M, Bshara W, ... Omilian AR, et al. Whole-genome sequencing of a malignant granular cell tumor with metabolic response to pazopanib. Cold Spring Harbor Molecular Case Studies. 1: a000380. PMID 27148567 DOI: 10.1101/mcs.a000380  0.244
2020 Benefield HC, Zirpoli GR, Allott EH, Shan Y, Hurson AN, Omilian AR, Khoury T, Hong CC, Olshan AF, Bethea TN, Bandera EV, Palmer JR, Ambrosone CB, Troester MA. Epidemiology of basal-like and luminal breast cancers among black women in the AMBER consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33097496 DOI: 10.1158/1055-9965.EPI-20-0556  0.241
2018 Morrison C, Pabla S, Conroy JM, Nesline MK, Glenn ST, Dressman D, Papanicolau-Sengos A, Burgher B, Andreas J, Giamo V, Qin M, Wang Y, Lenzo FL, Omilian A, Bshara W, et al. Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden. Journal For Immunotherapy of Cancer. 6: 32. PMID 29743104 DOI: 10.1186/S40425-018-0344-8  0.24
2023 Cheng TD, Zhang R, Gong Z, Qin B, Cannioto RA, Datta S, Zhang W, Omilian AR, Yao S, Khoury T, Hong CC, Bandera EV, Ambrosone CB. Association Between Recreational Physical Activity and mTOR Signaling Pathway Protein Expression in Breast Tumor Tissue. Cancer Research Communications. 3: 395-403. PMID 36895729 DOI: 10.1158/2767-9764.CRC-22-0405  0.236
2013 Burkhart C, Paszkiewicz G, Gawron L, Kohrn R, Purmal A, Repasky E, Morrison C, Omilian A, Gudkov A, Gurova K. Curaxin Cbl0137 Demonstrates Significant Antitumor Activity Against Fact-Positive Patient-Derived Pancreatic Ductal Adenocarcinoma Annals of Oncology. 24: iv49. DOI: 10.1093/Annonc/Mdt203.44  0.234
2023 Iyer HS, Zeinomar N, Omilian AR, Perlstein M, Davis MB, Omene CO, Pawlish K, Demissie K, Hong CC, Yao S, Ambrosone CB, Bandera EV, Qin B. Neighborhood Disadvantage, African Genetic Ancestry, Cancer Subtype, and Mortality Among Breast Cancer Survivors. Jama Network Open. 6: e2331295. PMID 37647068 DOI: 10.1001/jamanetworkopen.2023.31295  0.234
2021 Mongiovi JM, Hong CC, Zirpoli GR, Khoury T, Omilian AR, Qin B, Bandera EV, Yao S, Ambrosone CB, Gong Z. Genetic Variants in and Genes and Breast Cancer Risk in White and Black Women. Frontiers in Oncology. 11: 679998. PMID 34249719 DOI: 10.3389/fonc.2021.679998  0.232
2021 Yao S, Cheng TD, Elkhanany A, Yan L, Omilian A, Abrams SI, Evans S, Hong CC, Qi Q, Davis W, Liu S, Bandera EV, Odunsi K, Takabe K, Khoury T, et al. Breast Tumor Microenvironment in Black Women: A Distinct Signature of CD8+ T Cell Exhaustion. Journal of the National Cancer Institute. PMID 33395700 DOI: 10.1093/jnci/djaa215  0.231
2023 Roy AM, George A, Attwood K, Alaklabi S, Patel A, Omilian AR, Yao S, Gandhi S. Effect of neighborhood deprivation index on breast cancer survival in the United States. Breast Cancer Research and Treatment. PMID 37542631 DOI: 10.1007/s10549-023-07053-4  0.231
2015 Payne Ondracek R, Cheng J, Gangavarapu KJ, Azabdaftari G, Woltz J, Brese E, Omilian A, Bshara W, Huss WJ, Mohler JL, Marshall JR. Impact of devascularization and tissue procurement on cell number and RNA integrity in prostatectomy tissue. The Prostate. 75: 1910-5. PMID 26350767 DOI: 10.1002/Pros.23087  0.227
2021 Cheng TD, Omilian AR, Yao S, Zhang W, Datta S, Bshara W, Ondracek RP, Davis W, Liu S, Hong CC, Bandera EV, Khoury T, Ambrosone CB. Body fatness and breast cancer risk in relation to phosphorylated mTOR expression in a sample of predominately Black women. Breast Cancer Research : Bcr. 23: 77. PMID 34330319 DOI: 10.1186/s13058-021-01458-z  0.216
2022 Lee LH, Davis L, Ylagan L, Omilian AR, Attwood K, Firat C, Shia J, Paty PB, Cance WG. Identification of a Subset of Stage I Colorectal Cancer Patients with High Recurrence Risk. Journal of the National Cancer Institute. PMID 35094080 DOI: 10.1093/jnci/djac023  0.139
2018 Chander A, Beshai B, Attwood K, Omilian A, Qiu J. P3.09-02 Utilization of Laboratory Developed Tests for PD-L1 Evaluation is Dependent on Tumor Type Journal of Thoracic Oncology. 13: S947. DOI: 10.1016/j.jtho.2018.08.1771  0.125
2023 Roy AM, George A, Attwood K, Alaklabi S, Patel A, Omilian AR, Yao S, Gandhi S. Effect of Neighborhood Deprivation Index on Breast Cancer Survival in the United States. Research Square. PMID 37066175 DOI: 10.21203/rs.3.rs-2763010/v1  0.116
Hide low-probability matches.